Hyperthermia With Flexible Electrode-typed 2-MHz Device During Radiotherapy for Solid Tumors
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
The Intersection of Oncology Care and Worker Well-Being
- Status
- RECRUITING
- Phase
- N/A
To Evaluate the Safety, Pharmacokinetic and the Effect of Food After Administration of ABN401 in Healthy Adult Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of IBI325 in Patients With Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Status
- RECRUITING
- Phase
- PHASE1
Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.
- Status
- RECRUITING
- Phase
- N/A
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Study of KD6001 in Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
YL-13027 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of FCN-098 in Patients With Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1